XML 230 R157.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-based participation plans for employees (Details 4)
Pure in Millions, $ / shares in Millions
 12 Months Ended
Dec. 31, 2022
$ / shares
Dec. 31, 2021
$ / shares
Equity-Based Participation Annual Incentive RSU [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.2 0.2
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 74.7 $ 87.5
Equity Based Participation Annual Incentive Restricted Shares [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.1 0.1
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 85.0 $ 97.0
Equity Based Participation Share savings plans RSU [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.4 0.4
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 75.0 $ 86.9
Equity Based Participation Share savings plans Shares [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 1.2 1.1
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 85.0 $ 97.0
Equity-Based Participation Employee share purchase plan [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.8  
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 82.8  
Equity Based Participation Novartis Equity Plan Select North America RSU [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 4.9 4.3
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 74.5 $ 86.9
Based Participation Novartis Equity Plan Select outside North America RSU [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 2.0 1.8
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 75.1 $ 86.9
Equity Based Participation Novartis Equity Plan Select outside North America Restricted Shares [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.7 0.6
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 85.0 $ 97.0
Equity Based Participation Long Term Performance PSU Plan [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 1.7 1.8
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 82.0 $ 89.5
Equity Based Participation Other share awards RSU [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.5 0.6
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 76.3 $ 78.4
Equity Based Participation Other share awards Restricted Shares [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.1  
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 86.9  
Equity Based Participation Other share awards Shares [member]    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Granted, number of shares 0.1 0.1
Weighted average exercise price of other equity instruments granted in share-based payment arrangement $ 86.1 $ 91.9